               SEQUENCE LISTING

<110> Alligator Bioscience AB

<120> Methods and compositions

<130> ALLBG/P76560PC

<150> GB2004677.7
<151> 2020-03-31

<160> 70

<170> BiSSAP 1.3.6

<210> 1
<211> 117
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1132/1133 Variable heavy chain (VH)

<400> 1
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              
Ser Gly Ile Gly Ser Tyr Gly Gly Gly Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ala Arg Tyr Val Asn Phe Gly Met Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         
Val Thr Val Ser Ser 
        115         

<210> 2
<211> 107
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1132/1133 Variable light chain (VL)

<400> 2
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Gly Arg Asn Pro Pro 
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         

<210> 3
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1132/1133 VH CDR1

<400> 3
Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               

<210> 4
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1132/1133 VH CDR2

<400> 4
Ile Gly Ser Tyr Gly Gly Gly Thr 
1               5               

<210> 5
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1132/1133 VH CDR3

<400> 5
Ala Arg Tyr Val Asn Phe Gly Met Asp Tyr 
1               5                   10  

<210> 6
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1132/1133 VL CDR1

<400> 6
Gln Ser Ile Ser Ser Tyr 
1               5       

<210> 7
<400> 7
000

<210> 8
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1132/1133 VL CDR3

<400> 8
Gln Gln Tyr Gly Arg Asn Pro Pro Thr 
1               5                   

<210> 9
<211> 351
<212> DNA
<213> Artificial Sequence


<220> 
<223> Antibody 1132/1133 Variable heavy chain (VH)

<400> 9
gaggtgcagc tgttggagag cgggggaggc ttggtacagc ctggggggtc cctgcgcctc      60

tcctgtgcag ccagcggatt cacctttagc agctatgcca tgagctgggt ccgccaggct     120

ccagggaagg ggctggagtg ggtctcaggt attggttctt acggtggtgg tacatactat     180

gcagactccg tgaagggccg gttcaccatc tcccgtgaca attccaagaa cacgctgtat     240

ctgcaaatga acagcctgcg tgccgaggac acggctgtat attattgtgc gcgctacgtt     300

aacttcggta tggactattg gggccaggga accctggtca ccgtctcctc a              351


<210> 10
<211> 321
<212> DNA
<213> Artificial Sequence


<220> 
<223> Antibody 1132/1133 Variable light chain (VL)

<400> 10
gacatccaga tgacccagtc tccatcctcc ctgagcgcat ctgtaggaga ccgcgtcacc      60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca     120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180

cgtttcagtg gcagtggaag cgggacagat ttcactctca ccatcagcag tctgcaacct     240

gaagattttg caacttatta ctgtcaacag tacggtcgta acccgcccac ttttggccag     300

gggaccaagc tggagatcaa a                                               321


<210> 11
<211> 119
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1140/1135 Variable heavy chain (VH)

<400> 11
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              
Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ala Arg Gly Pro Val Tyr Ser Ser Val Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         
Thr Leu Val Thr Val Ser Ser 
        115                 

<210> 12
<211> 107
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1140/1135 Variable light chain (VL)

<400> 12
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Tyr 
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         

<210> 13
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1140/1135 VH CDR1

<400> 13
Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               

<210> 14
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1140/1135 VH CDR2

<400> 14
Ile Ser Gly Ser Gly Gly Ser Thr 
1               5               

<210> 15
<211> 12
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1140/1135 VH CDR3

<400> 15
Ala Arg Gly Pro Val Tyr Ser Ser Val Phe Asp Tyr 
1               5                   10          

<210> 16
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1140/1135 VL CDR1

<400> 16
Gln Ser Ile Ser Ser Tyr 
1               5       

<210> 17
<400> 17
000

<210> 18
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1140/1135 VL CDR3

<400> 18
Gln Gln Ser Tyr Ser Thr Pro Tyr Thr 
1               5                   

<210> 19
<211> 357
<212> DNA
<213> Artificial Sequence


<220> 
<223> Antibody 1140/1135 Variable heavy chain (VH)

<400> 19
gaggtgcagc tgttggagag cgggggaggc ttggtacagc ctggggggtc cctgcgcctc      60

tcctgtgcag ccagcggatt cacctttagc agctatgcca tgagctgggt ccgccaggct     120

ccagggaagg ggctggagtg ggtctcagct attagtggta gtggtggtag cacatactat     180

gcagactccg tgaagggccg gttcaccatc tcccgtgaca attccaagaa cacgctgtat     240

ctgcaaatga acagcctgcg tgccgaggac acggctgtat attattgtgc gcgcggtccg     300

gtttactctt ctgtttttga ctattggggc cagggaaccc tggtcaccgt ctcctca        357


<210> 20
<211> 321
<212> DNA
<213> Artificial Sequence


<220> 
<223> Antibody 1140/1135 Variable light chain (VL)

<400> 20
gacatccaga tgacccagtc tccatcctcc ctgagcgcat ctgtaggaga ccgcgtcacc      60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca     120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180

cgtttcagtg gcagtggaag cgggacagat ttcactctca ccatcagcag tctgcaacct     240

gaagattttg caacttatta ctgtcaacag agttacagta ccccttatac ttttggccag     300

gggaccaagc tggagatcaa a                                               321


<210> 21
<211> 117
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1150/1151 Variable heavy chain (VH)

<400> 21
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              
Ser Gly Ile Gly Gly Ser Ser Ser Tyr Thr Ser Tyr Ala Asp Ser Val 
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ala Arg Tyr Tyr Ser Tyr His Met Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         
Val Thr Val Ser Ser 
        115         

<210> 22
<211> 107
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1150/1151 Variable light chain (VL)

<400> 22
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      
Asp His Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Gly Ser Ala Pro Pro 
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         

<210> 23
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1150/1151 VH CDR1

<400> 23
Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               

<210> 24
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1150/1151 VH CDR2

<400> 24
Ile Gly Gly Ser Ser Ser Tyr Thr 
1               5               

<210> 25
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1150/1151 VH CDR3

<400> 25
Ala Arg Tyr Tyr Ser Tyr His Met Asp Tyr 
1               5                   10  

<210> 26
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1150/1151 VL CDR1

<400> 26
Gln Ser Ile Ser Ser Tyr 
1               5       

<210> 27
<400> 27
000

<210> 28
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1150/1151 VL CDR3

<400> 28
Gln Gln Tyr Gly Ser Ala Pro Pro Thr 
1               5                   

<210> 29
<211> 351
<212> DNA
<213> Artificial Sequence


<220> 
<223> Antibody 1150/1151 Variable heavy chain (VH)

<400> 29
gaggtgcagc tgttggagag cgggggaggc ttggtacagc ctggggggtc cctgcgcctc      60

tcctgtgcag ccagcggatt cacctttagc agctatgcca tgagctgggt ccgccaggct     120

ccagggaagg ggctggagtg ggtctcaggt attggtggtt cttcttctta cacatcttat     180

gcagactccg tgaagggccg gttcaccatc tcccgtgaca attccaagaa cacgctgtat     240

ctgcaaatga acagcctgcg tgccgaggac acggctgtat attattgtgc gcgctactac     300

tcttaccata tggactattg gggccaggga accctggtca ccgtctcctc a              351


<210> 30
<211> 321
<212> DNA
<213> Artificial Sequence


<220> 
<223> Antibody 1150/1151 Variable light chain (VL)

<400> 30
gacatccaga tgacccagtc tccatcctcc ctgagcgcat ctgtaggaga ccacgtcacc      60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca     120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180

cgtttcagtg gcagtggaag cgggacagat ttcactctca ccatcagcag tctgcaacct     240

gaagattttg caacttatta ctgtcaacag tacggttctg ctccgcccac ttttggccag     300

gggaccaagc tggagatcaa a                                               321


<210> 31
<211> 116
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1107/1108 Variable heavy chain (VH)

<400> 31
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              
Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ala Arg Arg Val Trp Gly Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         
Thr Val Ser Ser 
        115     

<210> 32
<211> 107
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1107/1108 Variable light chain (VL)

<400> 32
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Gly Val Tyr Pro Phe 
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         

<210> 33
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1107/1108 VH CDR1

<400> 33
Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               

<210> 34
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1107/1108 VH CDR2

<400> 34
Ile Ser Gly Ser Gly Gly Ser Thr 
1               5               

<210> 35
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1107/1108 VH CDR3

<400> 35
Ala Arg Arg Val Trp Gly Phe Asp Tyr 
1               5                   

<210> 36
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1107/1108 VL CDR1

<400> 36
Gln Ser Ile Ser Ser Tyr 
1               5       

<210> 37
<400> 37
000

<210> 38
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody 1107/1108 VL CDR3

<400> 38
Gln Gln Tyr Gly Val Tyr Pro Phe Thr 
1               5                   

<210> 39
<211> 350
<212> DNA
<213> Artificial Sequence


<220> 
<223> Antibody 1107/1108 Variable heavy chain (VH)

<400> 39
gaggtgcagc tgttggagag cgggggaggc ttggtacagc ctggggggtc cctgcgcctc      60

tcctgtgcag ccagcggatt cacctttagc agctatgcca tgagctgggt ccgccaggct     120

ccagggaagg ggctggagtg ggtctcagct attagtggta gtggtggtag cacatactat     180

gcagactccg tgaagggccg gttcaccatc tcccgtgaca attccaagaa cacgctgtat     240

ctgcaaatga acagcctgcg tgccgaggac acggctgtat attattgtgc gcgccgtgtt     300

tggggttttg actattgggg ccagggaacc ctggtcaccg tctcctcagg                350


<210> 40
<211> 321
<212> DNA
<213> Artificial Sequence


<220> 
<223> Antibody 1107/1108 Variable light chain (VL)

<400> 40
gacatccaga tgacccagtc tccatcctcc ctgagcgcat ctgtaggaga ccgcgtcacc      60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca     120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca     180

cgtttcagtg gcagtggaag cgggacagat ttcactctca ccatcagcag tctgcaacct     240

gaagattttg caacttatta ctgtcaacag tacggtgttt acccgttcac ttttggccag     300

gggaccaagc tggagatcaa a                                               321


<210> 41
<211> 119
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody G12 (ADC-1013) Variable heavy chain (VH)

<400> 41
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Leu 
        35                  40                  45              
Ser Tyr Ile Ser Gly Gly Ser Ser Tyr Ile Phe Tyr Ala Asp Ser Val 
    50                  55                  60                  
Arg Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Glu Asn Ala Leu Tyr 
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ala Arg Ile Leu Arg Gly Gly Ser Gly Met Asp Leu Trp Gly Gln Gly 
            100                 105                 110         
Thr Leu Val Thr Val Ser Ser 
        115                 

<210> 42
<211> 112
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody G12 (ADC-1013) Variable light chain (VL)

<400> 42
Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      
Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          
Tyr Asn Val Tyr Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              
Leu Ile Tyr Gly Asn Ile Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  
Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu 
65                  70                  75                  80  
Arg Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Lys Ser 
                85                  90                  95      
Ile Ser Gly Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly 
            100                 105                 110         



<210> 43
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody G12 (ADC-1013) VH CDR1

<400> 43
Gly Phe Thr Phe Ser Thr Tyr Gly Met His 
1               5                   10  

<210> 44
<211> 26
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody G12 (ADC-1013) VH CDR2

<400> 44
Gly Lys Gly Leu Glu Trp Leu Ser Tyr Ile Ser Gly Gly Ser Ser Tyr 
1               5                   10                  15      
Ile Phe Tyr Ala Asp Ser Val Arg Gly Arg 
            20                  25      

<210> 45
<211> 13
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody G12 (ADC-1013) VH CDR3

<400> 45
Cys Ala Arg Ile Leu Arg Gly Gly Ser Gly Met Asp Leu 
1               5                   10              

<210> 46
<211> 15
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody G12 (ADC-1013) VL CDR1

<400> 46
Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly Tyr Asn Val Tyr 
1               5                   10                  15  

<210> 47
<211> 7
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody G12 (ADC-1013) VL CDR2

<400> 47
Gly Asn Ile Asn Arg Pro Ser 
1               5           

<210> 48
<211> 12
<212> PRT
<213> Artificial Sequence


<220> 
<223> Antibody G12 (ADC-1013) VL CDR3

<400> 48
Cys Ala Ala Trp Asp Lys Ser Ile Ser Gly Leu Val 
1               5                   10          

<210> 49
<211> 357
<212> DNA
<213> Artificial Sequence


<220> 
<223> Antibody G12 (ADC-1013) Variable heavy chain (VH)

<400> 49
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc      60

tcctgtgcag cctctggatt caccttcagt acttatggca tgcactgggt ccgccaggct     120

ccagggaagg ggctggagtg gctttcatat attagtggtg gtagtagtta cattttctac     180

gcagactcag tgaggggccg attcaccatc tccagagaca actccgagaa cgcgctgtat     240

ctgcaaatga acagcctgag agccgaggac acggccgtgt attactgtgc gagaatatta     300

agaggcggga gcggtatgga cctctggggc caaggtacac tggtcaccgt gagctca        357


<210> 50
<211> 336
<212> DNA
<213> Artificial Sequence


<220> 
<223> Antibody G12 (ADC-1013) Variable light chain (VL)

<400> 50
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc      60

tcttgcactg ggagcagctc caacatcggg gcgggttaca atgtatactg gtatcagcag     120

ctcccaggaa cggcccccaa actcctcatc tatggtaaca tcaatcggcc ctcaggggtc     180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cagtgggctc     240

cggtccgagg atgaggctga ttattactgt gcagcatggg ataagagcat ttctggtctg     300

gttttcggcg gaggaaccaa gctgacggtc ctaggt                               336


<210> 51
<211> 33
<212> PRT
<213> Artificial Sequence


<220> 
<223> Z33

<400> 51
Phe Asn Met Gln Gln Gln Arg Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      
Asn Leu Asn Glu Glu Gln Arg Asn Ala Lys Ile Lys Ser Ile Arg Asp 
            20                  25                  30          
Asp 
    

<210> 52
<211> 21
<212> PRT
<213> Artificial Sequence


<220> 
<223> K3

<400> 52
Lys Ile Ala Ala Leu Lys Glu Lys Ile Ala Ala Leu Lys Glu Lys Ile 
1               5                   10                  15      
Ala Ala Leu Lys Glu 
            20      

<210> 53
<211> 28
<212> PRT
<213> Artificial Sequence


<220> 
<223> K4

<400> 53
Lys Ile Ala Ala Leu Lys Glu Lys Ile Ala Ala Leu Lys Glu Lys Ile 
1               5                   10                  15      
Ala Ala Leu Lys Glu Lys Ile Ala Ala Leu Lys Glu 
            20                  25              

<210> 54
<211> 21
<212> PRT
<213> Artificial Sequence


<220> 
<223> coiled-coil peptide tag E3

<400> 54
Glu Ile Ala Ala Leu Glu Lys Glu Ile Ala Ala Leu Glu Lys Glu Ile 
1               5                   10                  15      
Ala Ala Leu Glu Lys 
            20      

<210> 55
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 55
Gly Ser Ser Ser Ser 
1               5   

<210> 56
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 56
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10      

<210> 57
<211> 13
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 57
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Ala Pro 
1               5                   10              

<210> 58
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 58
Asn Phe Ser Gln Pro 
1               5   

<210> 59
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 59
Lys Arg Thr Val Ala 
1               5   

<210> 60
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 60
Gly Gly Gly Ser Gly Gly Gly Gly 
1               5               

<210> 61
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 61
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10  

<210> 62
<211> 15
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 62
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10                  15  

<210> 63
<211> 18
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 63
Gly Ser Thr Ser Gly Ser Gly Lys Pro Gly Ser Gly Glu Gly Ser Thr 
1               5                   10                  15      
Lys Gly 
        

<210> 64
<211> 15
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 64
Thr His Thr Cys Pro Pro Cys Pro Glu Pro Lys Ser Ser Asp Lys 
1               5                   10                  15  

<210> 65
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 65
Gly Gly Gly Ser 
1               

<210> 66
<211> 13
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 66
Glu Ala Ala Lys Glu Ala Ala Lys Gly Gly Gly Gly Ser 
1               5                   10              

<210> 67
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Linker

<400> 67
Glu Ala Ala Lys Glu Ala Ala Lys 
1               5               

<210> 68
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> tetanus toxin (TTx)

<400> 68
Met Thr Thr Glu 
1               

<210> 69
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> FLAG-tag

<400> 69
Asp Tyr Lys Asp Asp Asp Asp Lys 
1               5               

<210> 70
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> OVA peptide

<400> 70
Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               

